RBC Bioscience (ROCO:6848) Debt-to-Revenue : 2.92 (As of Dec. 2023)

RBC Bioscience Debt-to-Revenue Chart

RBC Bioscience Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Revenue	Get a 7-Day Free Trial					2.55	2.50	3.52	2.75	2.92

Competitive Comparison of RBC Bioscience's Debt-to-Revenue

For the Biotechnology subindustry, RBC Bioscience's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RBC Bioscience's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, RBC Bioscience's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where RBC Bioscience's Debt-to-Revenue falls into.

RBC Bioscience Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

RBC Bioscience's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

RBC Bioscience's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Dec. 2023) Revenue data.

RBC Bioscience Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of RBC Bioscience's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

RBC Bioscience (ROCO:6848) Business Description